Abivax (ABVX) Total Non-Current Liabilities (2021 - 2026)
Abivax (ABVX) reported Total Non-Current Liabilities of $28.19 million for Q2 2026, down 55.2% from $62.9 million a year earlier and down 56.5% from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Abivax posted Total Non-Current Liabilities of $74.7 million, down 2.3% from FY2024.
- Total Non-Current Liabilities has a four-year compound annual growth rate of 5.5% (FY2021 to FY2025).
- By year, Total Non-Current Liabilities came in at $76.46 million in FY2024 (+75.2%), $43.65 million in FY2023 (+145.2%), $17.8 million in FY2022 (-70.5%) and $60.39 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q4 2022.
- Year over year, Total Non-Current Liabilities gained in two of the last five quarters, with an average decline of 2.7%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $64.76 million (Q1 2026), $76.96 million (Q4 2025) and $72.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Abivax | 6.50 Bn | 4.14 Bn | - | 27.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.70 Mn |
| Mar 31, 2026 | 63.39 Mn |
| Dec 31, 2025 | 77.67 Mn |
| Sep 30, 2025 | 72.80 Mn |
| Jun 30, 2025 | 65.17 Mn |
| Mar 31, 2025 | 73.38 Mn |
| Dec 31, 2024 | 73.51 Mn |
| Jun 30, 2024 | 83.58 Mn |
| Dec 31, 2023 | 44.67 Mn |
| Dec 31, 2022 | 18.01 Mn |
| Dec 31, 2021 | 57.79 Mn |
API Access
Abivax Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();